Atlas FDA

EVOLYSSE™ SMOOTH and EVOLYSSE™ FORM

FDA premarket approval P240022 · decided 2025-02-13

Approval details

PMA number
P240022
Trade name
EVOLYSSE™ SMOOTH and EVOLYSSE™ FORM
Generic name
Implant, dermal, for aesthetic use
Applicant
Symatese
Date received
2024-06-21
Decision date
2025-02-13
Days to decision
237 days
Decision code
APPR
Product code
LMH
Advisory committee
General, Plastic Surgery
Expedited review
No
Location
Chaponost
Statement
Dermal and subdermal injection to correct moderate to severe dynamic facial wrinkles and folds (such as NLFs) in adults 22 years or older.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.